Stem Cell Manufacturing Market 2028 By Product, Application, End User | The Insight Partners

report image

Stem Cell Manufacturing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Stem Cell Lines, Instruments, Culture Media, Consumables); Application (Research Applications, Clinical Applications, Cell and Tissue Banking); End User (Pharmaceutical and Biotechnology Companies, Hospitals and Surgical Centers, Academic Institutes and Research Laboratories, CROs, Cell Banks and Tissue Banks)

Report Code: TIPBT00002553 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


Within the rapidly growing stem cell market, stem cell manufacturing is important. Scale-up is needed to take a cell-based therapeutic from pre-clinical to later clinical stages and commercial production. Stem cell manufacturing focuses on the technologies that will enable the current laboratory-based practice of stem cell tissue culture to be transferred to the clinic as therapeutics while maintaining product and process control, automation, reproducibility, validation, and safety.


The "Global Stem Cell Manufacturing Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the stem cell manufacturing market with detailed market segmentation by product, application, end user, and geography. The report provides key statistics on the market status of the leading stem cell manufacturing market players and offers key trends and opportunities in the market.


  •   Based on product, the global stem cell manufacturing market is segmented into stem cell lines, instruments, culture media, and consumables.
  •   On the basis of application, the market is segmented into research applications, clinical applications, and cell and tissue banking.
  •   Based on end user, the market is bifurcated into pharmaceutical and biotechnology, hospitals and surgical centers, academic institutes and research laboratories, cros, and cell banks and tissue banks.



  •   Growing Public Awareness of Stem Cell Products' Therapeutic Potential.
  •   Growing Public-Private Funding and Investments in Stem Cell Research.
  •   Technological Advancements in stem cell manufacturing and Preservation.
  •   Development of Advanced Genomic Analysis Techniques for Stem Cell Manufacturing Quality Control.


  •   High Operational Costs Associated with Stem Cell Manufacturing and Banking


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The stem cell manufacturing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the stem cell manufacturing market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. Stem cells seem to have significant potential to treat COVID?19. In addition, scientists seem to be willing to explore any available treatments, such as stem cell therapy, due to the exponential rise in the number of deaths caused by COVID19. Thus, stem cell manufacturing market is positively impacted due to COVID-19.


The report covers key developments in the stem cell manufacturing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from stem cell manufacturing market are anticipated to lucrative growth opportunities in the future with the rising demand for stem cell manufacturing in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the stem cell manufacturing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Merck KGaA
  •   Thermo Fisher Scientific, Inc.
  •   BD
  •   Bio-Rad Laboratories, Inc.
  •   Miltenyi Biotec
  •   Pharmicell Co., Ltd
  •   Takara Bio Inc.
  •   STEMCELL Technologies Inc.
  •   Osiris Therapeutics, Inc.
  •   NuVasive, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies

1. Merck KGaA
2. Thermo Fisher Scientific, Inc.
3. BD
4. Bio-Rad Laboratories, Inc.
5. Miltenyi Biotec
6. Pharmicell Co., Ltd
7. Takara Bio Inc.
8. STEMCELL Technologies Inc.
9. Osiris Therapeutics, Inc.
10. NuVasive, Inc.
11. Becton, Dickinson and Company
12. Pharmicell (South Korea)
13. Anterogen
14. Cellular Dynamics International
16. Lonza Group
17. Holostem Terapie Avanzate
18. Pluristem Therapeutics
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount